Kenneth W. Duncan,Richard Chesworth,Michael John Munchhof
申请号：
US15150759
公开号：
US10150758B2
申请日:
2016.05.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
